Article: Driving Progress Through Collaboration
A consortium model of pharmaceutical players helps The Avoca Group change the clinical trial execution process
Read MoreNews & Events
MAGI’s Clinical Research vConference
April 26 - May 6, 2021 | Virtual
Join Avoca for the session: "Powerful Quality Management Systems for Sponsors, Sites and CROs"
Webinar: Clinical Quality Management System Optimization
April 15, 2021 | 11:00am – 12:00pm EDT
Ensure you are inspection ready during the changing trial landscape imposed by COVID-19 and resultant adjustments in regulations
5th Global Clinical Quality Conference
April 7-8, 2021 | Virtual
Join Avoca for the session: "Distinguish Key Risk Indicators (KRIs) from Quality Tolerance Limits (QTLs) and Why This is Important"
Webinar: How To Realize The Efficiency Benefits Of ICH E6 (R3) Before It’s Released
March 30, 2021 | 1:00 – 2:00pm EDT
ICH E6 (R3) is coming at a time when life science organizations still are struggling to adopt ICH E6 (R2). But should organizations wait until these guidelines are ratified to realize the intended benefits?
Informa Connect’s Risk-Based Quality Management
December 2-3, 2020 | Virtual
Join Avoca's session: "ICH E6(R3) Review: RBQM Considerations within Annex 2 Applied to Non-Traditional Trials"
2020 Avoca Quality and Innovation Summit
October 14-15, 2020 | Virtual
Now in its ninth year, the Avoca Summit focuses on quality and the adoption of innovative technology in the execution of clinical trials.
Novo Nordisk Receives First Place in ACRP-Avoca Sponsor Quality Awards
Press Release – September 30, 2020 Novo Nordisk was recognized with the ACRP-Avoca Sponsor Quality Award during the ACRP-Avoca Quality Congress this month. The Association of Clinical Research Professionals and The Avoca Group jointly recognized leading sponsors at the event. The following ACRP-Avoca Sponsor Quality Awards were announced: First Place – Novo Nordisk Second Place […]
Read More